Sorrento Therapeutics Inc

NASDAQ:SRNE   12:04:52 PM EDT
2.98
+0.10 (+3.30%)
Debt Financing / Related, Mergers / Acquisitions

Scilex Holding Company, A Sorrento Therapeutics Inc Subsidiary, And Vickers Vantage Corp I (“Spac”) Enter Into Letter Of Intent For Proposed Business Combination

Published: 12/06/2021 14:46 GMT
Sorrento Therapeutics Inc (SRNE) - Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Corp I (nasdaq: Vcka) (“spac”) Enter Into Letter of Intent for Proposed Business Combination.
Vickers Vantage Corp I - Deal Provides for a Pre-transaction Equity Value of Scilex of Approximately $1.5 Billion.
Vickers Vantage Corp I - Expected Gross Proceeds of Up to $140 Million From Deal.